Agencies
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Agencies | Published : May 3, 2014 5:13 PM IST
India can be a global leader in supplying affordable and high quality medicines to the world, and especially to the underdeveloped countries where such medicines do not reach the poor because of their high cost and the monopoly of foreign manufacturers, said a leading entrepreneur. 'India has emerged as the pharmacy of the world,' said Yousuf Hamied, chairman of pharmaceutical giant Cipla.
Hamied was speaking here Friday at the special screening of 'Fire in the Blood' - a documentary that depicts mass devastation in Africa, Asia and other parts of the global South due to obstruction of low cost anti-retroviral drugs used for the treatment of HIV/AIDS. The documentary was screened by the ministry of external affairs. 'India is not just contributing to the arena of medicines but also playing a humanitarian role by manufacturing medicines and supplying them at a low cost across the world,' he said. 'India is supplying essential medicines to people in all corners of the world. It is a great role towards humanity and also an initiative to curb the monopoly over medicines created by multinational pharma companies,' said Hamied. (Read: Indian pharma to reach new heights but will it be able to maintain quality?)
The 59-minute documentary tells the story of how western pharmaceutical companies and governments blocked access to low cost AIDS drugs for the global South countries in 1996 and afterwards - leading to 10 million deaths. 'The right to live should never be contingent to the ability to pay. Medicines that are required the most should never be sold in a monopoly. It is a very sad part of the story that countries, who need the medicines the most, are the ones who can't afford them because of the high cost and the patent by foreign companies to prevent any other firms from manufacturing the same drugs at a low cost,' he said. (Read: Brand India hit: Ghanian firms marketing fake drugs from India?)
'The companies having patent rights for medicines should allow other firms to manufacture the drugs and ask for royalty in return. Drugs manufacturing should never be seen as a money making business, especially when the motive is to save lives,' Hamied added.
Source: IANS
For more articles on healthcare, visit our healthcare section. Follow us on Facebook and Twitter for all the latest updates! For daily free health tips, sign up for our newsletter. And to join discussions on health topics of your choice, visit our forum.
